Therapeutics

+

SeaBeLife Biotech

Lilly Moran, 22 January, 2025, 0

SeaBeLife Biotech From cell death back to life

+

Blue Bees Therapeutics

Lilly Moran, 21 January, 2025, 0

Blue Bees Therapeutics First in a new class of cancer immunotherapies

+

Neurolieve Biosciences Ltd

Lilly Moran, 8 January, 2025, 0

Neurolieve Biosciences Ltd Neurolieve Biosciences aims to improve life quality for millions with peripheral neuropathic pain.

+

Theralia

Lilly Moran, 28 October, 2024, 0

Theralia We are developing targeted therapeutics for hard-to-treat diseases such as drug resistant bacterial infections or cancer Therapeutics Prototyping,...

+

ZeCardio Therapeutics

Davide D'Amico, 8 October, 2024, 0

ZeCardio Therapeutics We cure cardiovascular diseases! We keep the heart beating! Therapeutics Prototyping, preclinical Spain 2.000.000€ Status Pending IP Type...

+

Translational Pharma Solutions

Heidi Rohwer, 29 July, 2024, 0

Translational Pharma Solutions Repurposing haloperidol as an effective treatment for Spinal Muscular Atrophy Therapeutics Prototyping, preclinical Spain 1.500.000€ Status Approved...

+

ANKIAL

Heidi Rohwer, 22 May, 2024, 0

ANKIAL Boost cardiac energy supply to prevent sudden death in children Therapeutics Development, market readiness, clinical trial France 3.000.000€ Status...

+

OmniSpirant Limited

Heidi Rohwer, 9 May, 2024, 0

OmniSpirant Limited Game Changing Innovation in Cancer and Respiratory Medicine Therapeutics Prototyping, preclinical Ireland 10.000.000€ Status Approved IP Type Patent...

+

W2T Life

Heidi Rohwer, 14 February, 2024, 0

W2T Life Treatment of diabetic fatty acid liver disease and recurrent Bacterial Vaginosis Therapeutics Development, market readiness, clinical trial...

+

Celeris Therapeutics

Heidi Rohwer, 12 December, 2023, 0

Celeris Therapeutics The pioneer in AI-driven degrader discovery Therapeutics Prototyping, preclinical Austria 2.000.000€ Status Pending IP Type PCT Time -...